Investigation Overview
August 31, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Medivation Inc (NASDAQ:MDVN), was announced concerning whether the takeover of Medivation Inc by Pfizer Inc. for $81.50 per share is unfair to NASDAQ:MDVN stockholders. The investigation by a law firm concerns whether certain officers and directors of Medivation Inc breac...
You must register (for free) or login to view the entire investigation.